Article
A unique tolerizing dendritic cell phenotype induced by the synthetic triterpenoid CDDO-DFPA (RTA-408) is protective against EAE.
Scientific reports - 29 Aug 2017
Wei Hsi-Ju, Pareek Tej K, Liu Qi, Letterio John J
Abstract excerpt
Tolerogenic dendritic cells (DCs) have emerged as relevant clinical targets for the treatment of multiple sclerosis and other autoimmune disorders. However, the pathways essential for conferring the tolerizing DC phenotype and optimal methods for their induction remain an intense area of research. Triterpenoids are a class of small molecules with potent immunomodulatory activity linked to activation of Nrf2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
